WCG
AVNS

Weaver Consulting Group’s Avanos Medical AVNS Stock Holding History

Weaver Consulting Group’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-19
Closed -$1K – 193
2020
Q3 		$1K Hold
19
– – ﹤0.01% 870
2020
Q2 		$1K Hold
19
– – ﹤0.01% 844
2020
Q1 		$1K Hold
19
– – ﹤0.01% 747
2019
Q4 		$1K Hold
19
– – ﹤0.01% 781
2019
Q3 		$1K Hold
19
– – ﹤0.01% 760
2019
Q2 		$1K Hold
19
– – ﹤0.01% 749
2019
Q1 		$1K Buy
+19
New +$851 ﹤0.01% 1404

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Weaver Consulting Group's AVNS Position: Q4 2020 in Review

Weaver Consulting Group sold out of Avanos Medical (AVNS) in Q4 2020, closing a stake of 19 shares — an estimated $1K sold.

Weaver Consulting Group first reported a position in AVNS in Q1 2019 and held it in 7 quarters. The position peaked at $1K in Q3 2020. 281 funds tracked by Wall St. Rank hold AVNS as of Q4 2020.

  • Weaver Consulting Group reported no remaining Avanos Medical position as of Q4 2020 after selling out during the quarter.
  • Weaver Consulting Group sold 19 Avanos Medical shares in Q4 2020, an estimated $1K.
  • Weaver Consulting Group first reported a position in Avanos Medical in Q1 2019 and held it in 7 quarters.
  • Weaver Consulting Group's Avanos Medical position peaked at $1K in Q3 2020.
  • 281 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2020.

Based on Weaver Consulting Group's 13F filing for Q4 2020, filed 29 Jan 2021.